TraderTools connects the events around a stock, not just the price, the filing or the headline. Catalyst Convergence shows where an FDA date, a financing risk, insider buying, a federal contract and short interest land on the same ticker, and what changed since you last looked.
What Catalyst Convergence does
- Catalyst stack per ticker: seven layers (upcoming catalyst, financing and dilution, insiders, contracts, supply chain, short interest, news and filings) on one page, each with its source.
- Explainable Convergence Score: 0 to 100 evidence density, shown component by component. It measures how much independent evidence is stacked on a name. It is not a price prediction.
- What changed: a daily snapshot diff: score moves, dilution and cash-runway changes, moved or new catalyst dates, new insider purchases and new contract awards.
- Event screens: ready-made screens such as a catalyst ahead with thin cash and insider buying, or a contract cluster with high dilution risk.
- Contract-to-equity exposure: which public companies sit behind an agency or program, and the financing and catalyst context around them.
- Research brief: an evidence-linked brief per ticker, exportable.
- Decision alerts: 13 alert rules delivered in the app, by email or by webhook, such as "FDA decision in 7 days, but financing pressure is elevated".
Evidence and confidence
Every point carries an evidence label: primary-source fact, derived from a filing, cross-source match, probable relationship, unverified lead, stale data or conflicting sources. The score method, its weights and its known limits are published in the product and in the Data API documentation.
Who it is for
Event-driven, swing and biotech traders who want the collisions that matter, a catalyst arriving while the balance sheet is thin, or insiders buying ahead of a decision, without rebuilding the research by hand. See also the event-driven trading tools guide and the biotech trading tools guide.
Frequently asked questions
Is the Convergence Score a buy or sell signal?
No. It counts and weighs independent evidence on a ticker and explains each component. It does not predict price and is not investment advice.
Is it available through the API?
Yes. Convergence endpoints (score, stack, screens, changes, signals, contract exposure and briefs) are part of the keyed Data API.
What data does it not use?
It has no price, volume or analyst-coverage data, so it cannot screen for stocks that have not moved. Change history starts at the first daily snapshot.
See where the events line up
Research the catalyst, financing and insider context together before the market prices it in.
Explore TraderTools.pro